FDA Grants Breakthrough Therapy Designation to VERTANICAL’s VER-01 for Chronic Low Back Pain
The FDA breakthrough therapy chronic low back pain designation for VER-01 marks a key regulatory milestone. This cannabis-derived treatment targets a widespread condition with high opioid reliance. VER-01's expedited development could offer a safer,…
Delaware Lawmakers Debate Competing Regulatory Frameworks for Hemp-Derived THC Products
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Oklahoma Report Details Medical Cannabis Patient Outcomes and Program Challenges
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
7 on 7: The biggest stories from last week you might’ve missed
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Cannabinoid Pharmaceutical Financial Challenges in 2026
This article discusses cannabinoid pharmaceutical financial challenges impacting drug development in 2026. It highlights the economic struggles of companies developing cannabinoid therapies. Understanding these challenges is essential for clinicians…
Humboldt Planners Mull Cannabis’ Skunky Odor as Farm Expansion OK’d
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
TSA Policy Allows Medical Cannabis Through Airport Security Amidst State Law Nuances …
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Alabama Delays Automatic Medical Cannabis Rescheduling to Assess State Program Impact
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Luke O’Neill: More reasons to exercise — from a beefier brain to a cannabis-like high
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
The First Cannabis Drug to Earn FDA Breakthrough Therapy Status for Pain`
The FDA has granted Breakthrough Therapy Designation to VER-01, a full-spectrum cannabis extract, after two Phase 3 RCTs showed significant pain reduction in patients with chronic low back pain. VER-01 outperformed opioids on both pain relief and…
